Pediatrix® to Host Premier Neonatology Meetings March 1-6
February 24 2022 - 7:00AM
Business Wire
Leading industry conferences address the latest
topics in neonatal management designed to improve outcomes for
premature and critically ill newborns
Mednax, Inc. (NYSE: MD) and its Pediatrix-affiliated practices,
the nation’s leading providers of highly specialized health care
for women, children and babies, will host two premier meetings in
neonatal medicine at the Manchester Grand Hyatt in San Diego March
1-6. Specialty Review in Neonatology and NEO: The Conference for
Neonatology will take place concurrently, each addressing many of
the most critical and controversial issues that influence the
clinical practice of newborn medicine.
The meetings will host nearly 750 combined attendees consisting
of neonatology fellows, neonatologists, pediatricians, advanced
practice nurses and other allied health professionals from around
the country as well as exhibitors and sponsors.
Specialty Review in Neonatology | March 1-6
Now in its 11th year, Specialty Review is the premier board
certification review course of its type, offering an intensive and
comprehensive review of neonatology by expert faculty. The course
is invaluable to providers preparing for the subspecialty
certifying examinations in neonatal medicine, as well as new or
current fellows in training seeking a fundamental pathophysiology
and problem-based review in the specialty of neonatology.
Directed by David Weisoly, D.O., FAAP, neonatologist and medical
director at Pediatrix Neonatology of Houston, the six-day course
will feature an elite lineup of world-renowned speakers known for
their excellence in teaching and field expertise. Attendees will
also have the opportunity to participate in the popular “Battle of
the Boards” evening event. The Jeopardy-style rapid fire team
competition, complete with dinner, music and camaraderie, is
designed to enhance the learning experience in a fun, interactive
setting.
For more information, visit www.specialtyreview.com.
NEO: The Conference for Neonatology | March 2-4
Now in its 43rd year, NEO has established a reputation as the
top neonatology meeting in the U.S. Directed by Reese Clark, M.D.,
executive director of the Center for Research, Education, Quality
and Safety (CREQS) and vice president of clinical research for
Pediatrix, and Timothy Biela, M.D., neonatologist and medical
director at Pediatrix Neonatology of San Antonio, NEO continues its
longstanding tradition of providing the latest information on key
areas of neonatal management. The goal of the meeting continues to
be the improvement of neonatal outcomes through expert discussions
of optimal approaches in the neonatal intensive care unit
(NICU).
An esteemed panel of speakers comprised of several
Pediatrix-affiliated physicians and well-recognized faculty from
top institutions across the country will present over the course of
three days. A highly anticipated event on the agenda each year is
the presentation of the Legends of Neonatology Award. Established
in 2007, the award honors the remarkable individuals whose clinical
contributions have helped forge new ground in neonatal
medicine.
This year’s honoree is Jeffrey Gould, M.D., MPH, neonatologist
and perinatal epidemiologist at Stanford University School of
Medicine. Dr. Gould co-founded the California Perinatal Quality
Care Collaborative (CPQCC), the nation’s first statewide quality
improvement consortium that also serves as a platform for faculty,
trainee and inter-university collaborative translational research
in perinatal epidemiology, quality of care analysis and risk
reduction/quality improvement program development. CPQCC includes
138 California NICUs and under Dr. Gould’s leadership, has
developed quality improvement toolkits, conducted successful
multi-institutional quality improvement initiatives and has been
nationally and internationally recognized as a model for
regionalized perinatal quality improvement. To address the broader
needs of all pregnant women, he also founded the California
Maternal Quality Care Collaborative (CMQCC) in 2006 as a sister
organization to assess and improve the quality, outcomes and
disparities in the obstetric care of all women in California. In
addition to his innovative accomplishments in statewide
collaboration to improve the quality of perinatal care and health
outcomes, Dr. Gould has been published in more than 160
peer-reviewed publications in the areas of perinatal epidemiology
and quality improvement.
For more information, visit www.neoconference.com.
CREQS is accredited with commendation as a provider of
continuing medical education by the Accreditation Council for
Continuing Medical Education and continuing nursing education by
the American Nurses Credentialing Center’s Commission on
Accreditation. Specialty Review participants can earn up to 47.00
AMA PRA Category 1 Credits™ and Maintenance of Certification (MOC)
points in the American Board of Pediatrics’ MOC program. NEO
participants can earn up to 21.25 AMA PRA Category 1 Credits™ and
nursing contact hours.
ABOUT MEDNAX
Mednax, Inc. is a national medical group comprised of the
nation’s leading providers of physician services practicing under
the Pediatrix® Medical Group brand. Pediatrix-affiliated clinicians
are committed to providing coordinated, compassionate and
clinically excellent services to women, babies and children across
the continuum of care, both in hospital settings and office-based
practices. Specialties include obstetrics, maternal-fetal medicine
and neonatology complemented by 18 pediatric subspecialties,
including a newly expanded area of primary and urgent care clinics.
The group’s high-quality, evidence-based care is bolstered by
investments in research, education, quality-improvement and safety
initiatives. The company was founded in 1979 as a single
neonatology practice and today provides its highly focused and
often critical care services through more than 4,700 affiliated
physicians and other clinicians in 38 states and Puerto Rico. To
learn more about Pediatrix, visit www.pediatrix.com or follow us on
Facebook, Instagram, LinkedIn, Twitter and the Pediatrix blog.
Mednax investment information can be found at
www.mednax.com/investors.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220224005290/en/
Jennifer Gutierrez | Manager, Corporate Communications
954.384.0175 ext. 5684 | jennifer.gutierrez@pediatrix.com
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From May 2024 to Jun 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Jun 2023 to Jun 2024